ARCHIVED — Vol. 147, No. 38 — September 21, 2013

Warning This Web page has been archived on the Web.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

GOVERNMENT NOTICES

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 11489a (variation to Significant New Activity Notice No. 11489)

Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment and the Minister of Health have assessed information in respect of the substance silane, triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-, Chemical Abstracts Service Registry Number 51851-37-7, under section 83 of the Canadian Environmental Protection Act, 1999;

Whereas the Minister of the Environment published on January 28, 2006, Significant New Activity Notice No. 11489 in Part Ⅰ of the Canada Gazette, Vol. 140, No. 4;

Whereas the substance is not specified on the Domestic Substances List;

And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby varies Significant New Activity Notice No. 11489, pursuant to subsection 85(2) of the Canadian Environmental Protection Act, 1999, in accordance with the following Annex.

LEONA AGLUKKAQ
Minister of the Environment

ANNEX

1. Significant New Activity Notice No. 11489 is replaced by the following:

ANNEX

Information Requirements
(Section 85 of the Canadian Environmental Protection Act, 1999)

  1. In relation to the substance silane, triethoxy (3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-, a significant new activity is the use of the substance in Canada, in any quantity, other than its use as an industrial or commercial surface modification agent or as an industrial or commercial adhesion promoter between inorganic materials and fluoropolymers.
  2. Despite item 1, the use of the substance as a research and development substance, a site-limited intermediate substance or a contained substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), is not a new activity.
  3. The following information must be provided to the Minister, at least 90 days before the commencement of each proposed significant new activity:
    • (a) a description of the proposed significant new activity in relation to the substance;
    • (b) the information specified in Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the information specified in item 8 of Schedule 5 to those Regulations;
    • (d) the information specified in item 11 of Schedule 6 to those Regulations;
    • (e) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (f) the identification of every government department or government agency, either outside or within Canada, to which the person proposing the significant new activity has provided information regarding the use of the substance and if known, the department’s or agency’s file number and if any, the outcome of the department’s or agency’s assessment and risk management actions in relation to the substance imposed by the department or agency;
    • (g) if known, the three sites in Canada where the greatest quantity of the substance, in relation to the significant new activity, is anticipated to be used or processed and the estimated quantity by site;
    • (h) the test data and a test report from a 28-day repeated dose inhalation toxicity study in respect of the substance, conducted according to the methodology described in the Organisation for Economic Co-operation and Development (OECD) Test Guideline No. 412 titled Subchronic Inhalation Toxicity: 28-day Study, and in conformity with practices described in the OECD Principles of Good Laboratory Practice (“Principles of GLP”) set out in Annex 2 of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals, adopted on May 12, 1981. Both the OECD Test Guideline and Principles of GLP must be current at the time of the test; and
    • (i) all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they have access, and that are relevant to determining whether the substance is toxic or capable of becoming toxic.
  4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

EXPLANATORY NOTE

(This explanatory note is not part of the Significant New Activity Notice.)

A Significant New Activity Notice is a legal instrument issued by the Minister of the Environment pursuant to section 85 of the Canadian Environmental Protection Act, 1999. The Significant New Activity Notice sets out the appropriate information that must be provided to the Minister for assessment prior to the commencement of a new activity as described in the Notice.

Substances that are not listed on the Domestic Substances List can be manufactured or imported only by the person who has met the requirements set out in section 81 of the Canadian Environmental Protection Act, 1999. Under section 86 of the Canadian Environmental Protection Act, 1999, in circumstances where a Significant New Activity Notice is issued for a new substance, it is the responsibility of every person who transfers the physical possession or control of the substance to notify all persons to whom the possession or control is transferred of the obligation to comply with the Significant New Activity Notice and of the obligation to notify the Minister of the Environment of any new activity and all other information as described in the Notice. It is the responsibility of the users of the substance to be aware of and comply with the Significant New Activity Notice and to submit a Significant New Activity notification to the Minister prior to the commencement of a significant new activity associated with the substance. However, as mentioned in subsection 81(6) of the Canadian Environmental Protection Act, 1999, a Significant New Activity notification is not required when the proposed new activity is regulated under an act or regulations listed on Schedule 2 to the Canadian Environmental Protection Act, 1999.

A Significant New Activity Notice does not constitute an endorsement from Environment Canada or the Government of Canada of the substance to which it relates, or an exemption from any other laws or regulations that are in force in Canada and that may apply to this substance or activities involving the substance.

[38-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 15441

Rescinding Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment has previously imposed Significant New Activity Notice No. 15441 pertaining to the substance 2-Propenoic acid, 2-methyl-, methyl ester, polymer with hydrolyzed poly(vinyl acetate) and polyfluorooctyl acrylate, on April 18, 2009;

Whereas the Minister of the Environment and the Minister of Health have assessed additional information pertaining to the substance;

And whereas the ministers no longer suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby indicates pursuant to subsection 85(2) that subsection 81(4) of the Canadian Environmental Protection Act, 1999 no longer applies to the substance and rescinds Significant New Activity Notice No. 15441.

LEONA AGLUKKAQ
Minister of the Environment

[38-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 16138

Rescinding Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment has previously imposed Significant New Activity Notice No. 16138 pertaining to the substance 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, polymer with 1,1-dichloroethene and alkyl 2-propenoate, on December 25, 2010;

Whereas the Minister of the Environment and the Minister of Health have assessed additional information pertaining to the substance;

And whereas the ministers no longer suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby indicates pursuant to subsection 85(2) that subsection 81(4) of the Canadian Environmental Protection Act, 1999 no longer applies to the substance and rescinds Significant New Activity Notice No. 16138.

LEONA AGLUKKAQ
Minister of the Environment

[38-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notices Nos. 14888, 15312, 15313, 15314, 15315, 16266, 16267 and 16268

Rescinding Significant New Activity Notices

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment has previously imposed the Significant New Activity notices mentioned in the Annex;

Whereas the Minister of the Environment and the Minister of Health have assessed additional information pertaining to the substances concerned by these Significant New Activity notices;

And whereas the ministers no longer suspect that a significant new activity in relation to the substances may result in the substances becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby indicates pursuant to subsection 85(2) that subsection 81(4) of the Canadian Environmental Protection Act, 1999 no longer applies to the substances and rescinds the Significant New Activity notices mentioned in the Annex.

LEONA AGLUKKAQ
Minister of the Environment

ANNEX

  1. Significant New Activity Notice No. 14888 pertaining to the substance Siloxanes and Silicones, substituted alkyl Me, di-Me, Me substituted alkyl, polymers with stearyl acrylate, polyfluoro methacrylate and vinyl chloride, published on December 1, 2007, in Part Ⅰ of the Canada Gazette, Vol. 141, No. 48.
  2. Significant New Activity Notice No. 15312 pertaining to the substance 2-Propenoic acid, 2-hydroxyethyl ester, telomer with 2-mercaptoethanol, polyalkyleneglycol acrylate, polyalkyleneglycol polyacrylate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  3. Significant New Activity Notice No. 15313 pertaining to the substance 2-Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, polymer with polyalkyleneglycol acrylate, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  4. Significant New Activity Notice No. 15314 pertaining to the substance Polyfluoro acrylate, polymer with chloroethene, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  5. Significant New Activity Notice No. 15315 pertaining to the substance Polyfluoro acrylate, polymer with chloroethene, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  6. Significant New Activity Notice No. 16266 pertaining to the substance 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, telomer with 1-dodecanethiol and octadecyl 2-propenoate, Chemical Abstracts Service Registry No. 1259487-19-8, published on May 14, 2011, in Part Ⅰ of the Canada Gazette, Vol. 145, No. 20.
  7. Significant New Activity Notice No. 16267 pertaining to the substance 2-Propenoic acid, 2-methyl-, polymer with 2-hydroxyethyl 2-methyl-2-propenoate, α-(1-oxo-2-propen-1-yl)-ω-hydroxypoly (oxy-1,2-ethanediyl) and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, sodium salt, Chemical Abstracts Service Registry No. 1158951-86-0, published on April 30, 2011, in Part Ⅰ of the Canada Gazette, Vol. 145, No. 18.
  8. Significant New Activity Notice No. 16268 pertaining to 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer with 1-ethenyl-2-pyrrolidinone, 2-propenoic acid and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, sodium salt, Chemical Abstracts Service Registry No. 1206450-10-3, published on April 30, 2011, in Part Ⅰ of the Canada Gazette, Vol. 145, No. 18.

[38-1-o]

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. “Affected party” means a person who is not a competitor of the claimant and who uses, supplies or is otherwise involved in the use or supply of the controlled product at a work place, and includes

  • (a) a supplier of the controlled product;
  • (b) an employee at the work place;
  • (c) an employer at the work place;
  • (d) a safety and health professional for the work place;
  • (e) a safety and health representative or a member of a safety and health committee for the work place; and
  • (f) a person who is authorized in writing to represent
    • (i) a supplier referred to in paragraph (a) or an employer referred to in paragraph (c), or
    • (ii) an employee referred to in paragraph (b), except where that person is an official or a representative of a trade union that is not certified or recognized in respect of the work place.

To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part Ⅰ, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Directorate, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 0K9.

STEPHANIE REID
Chief Screening Officer

Claimant

Product Identifier (As shown on the MSDS)

Registry Number

MSDS Preparation Date (As shown on the MSDS)

Date of Decision

Ashland Canada Corp., Mississauga, Ontario

Presstige ® FB9170 Felt Cleaning and Conditioning Agent

8073

01/05/2011

November 26, 2012

Carolina Biological Supply Company, Burlington, North Carolina

Carolina’s Perfect Solution ® Concentrate

8100

02/10/2011

February 6, 2013

UNIVAR Canada Ltd., Richmond, British Columbia

ETHOX 4180

8124

17 January 2011

October 15, 2012

Purifics ES Inc., London, Ontario

ADX

8139

6-Apr-11

October 22, 2012

Engenium Chemical Corporation,* Calgary, Alberta * formerly Brine-Add Fluids Ltd., Calgary, Alberta

ONYXMUL S

8158

April 5, 2011

October 18, 2012

Weatherford Engineered Chemistry Canada Limited, Edmonton, Alberta

Smart Frac

8173

March 14, 2011

January 8, 2013

Weatherford Engineered Chemistry Canada Ltd., Edmonton, Alberta

AXE 707C

8181

September 9, 2008

January 8, 2013

Stepan Company, Northfield, Illinois

AGENT 3109-6

8184

03-23-2011

October 16, 2012

3M Canada Company, London, Ontario

3M(TM) SMC/Fiberglass Repair Adhesive-35 PN 08273 Part A

8188

2011/05/03

November 14, 2012

3M Canada Company, London, Ontario

3M™ SCREEN PRINTING UV INK SERIES 9861 LIGHT GREEN

8211

2011/10/05

October 31, 2012

3M Canada Company, London, Ontario

9875 Process Cyan

8212

2011/10/05

October 31, 2012

3M Canada Company, London, Ontario

3M ™ SCREEN PRINTING UV INK SERIES 9879 BLUE (GS)

8213

2011/10/05

October 31, 2012

3M Canada Company, London, Ontario

3M ™ SCREEN PRINTING UV INK 9882 TRANSPARENT BLUE

8214

2011/10/05

October 31, 2012

3M Canada Company, London, Ontario

3M™ SCREEN PRINTING UV INK SERIES 9891 BLUE VIOLET

8215

2011/10/05

October 31, 2012

3M Canada Company, London, Ontario

3M (TM) 227 PURPLE TRANSPARENT OFFSET INK

8246

2011/06/07

February 15, 2013

Milacron Marketing Company LLC, Cincinnati, Ohio

CIMPERIAL® 1080CFZ

8247

02-Nov-2011

November 6, 2012

Canyon Technical Services, Calgary, Alberta

CAN-1200

8251

6/29/2011

December 6, 2012

Canyon Technical Services, Calgary, Alberta

CAN-1203

8253

6/29/2011

December 6, 2012

3M Canada Company, London, Ontario

3M (TM )SCOTCHLITE (TM) TRANSPARENT SCREEN PRINTING INK 2916 BLUE VIOLET

8254

2011/06/28

February 15, 2013

Momentive Performance Materials, Markham, Ontario

SPUR+ 1015 LM Prepolymer Silyated Polyurethane Resin

8257

12/12/2011

March 5, 2013

GE Water & Process Technologies Canada, Oakville, Ontario

PROCHEM 3F29

8261

29-SEP-2011

October 31, 2012

BASF Canada Inc., Mississauga, Ontario

Dehypound® Advanced

8267

2011/07/09

December 14, 2012

BASF Canada Inc., Mississauga, Ontario

Versamine® C39

8270

2011/07/08

December 12, 2012

BASF Canada Inc., Mississauga, Ontario

Disponil®AFX 4070

8271

2001/07/08

December 23, 2012

BASF Canada Inc., Mississauga, Ontario

Waterpoxy ® 1455

8274

2011/07/08

December 12, 2012

JBI Canada Incorporated, Thorold, Ontario* * formerly Port Robinson, Ontario

Marble Traction

8275

May 3, 2011

October 5, 2012

VWR Education LTD., St. Catharines, Ontario

Simulated Anti-serum (Anti-A, Anti-B, Anti-RH)

8278

11-July-11

February 13, 2013

VWR Education LTD., St. Catharines, Ontario

Simulated Blood (Type A, Type B, Type AB, Type O)

8279

13-July-2011

January 29, 2013

HOUGHTON INTERNATIONAL INC.,* Valley Forge, Pennsylvania * formerly Houghton Canada Inc.

HOCUT 4549

8285

8 November 2011

February 14, 2013

Afton Chemical Corporation, Richmond, Virginia

HiTEC 485 Performance Additive

8286

8/4/2011

December 19, 2012

Calfrac Well Services Ltd., Calgary, Alberta

DWP-123

8293

January 14, 2011

October 23, 2012

Calfrac Well Services Ltd., Calgary, Alberta

DWP-213

8296

January 25, 2012

October 9, 2012

Calfrac Well Services Ltd., Calgary, Alberta

DWP-938

8298

March 5, 2012

November 22, 2012

Calfrac Well Services Ltd., Calgary, Alberta

DWP-948

8299

November 2, 2010

December 6, 2012

Calfrac Well Services Ltd., Calgary, Alberta

DWP-949

8300

February 2, 2011

December 6, 2012

Calfrac Well Services Ltd., Calgary, Alberta

DAP-401

8302

June 03, 2011

January 28, 2013

Calfrac Well Services Ltd., Calgary, Alberta

DWP-601

8303

November 4, 2010

January 28, 2013

Ashland Canada Corp., Mississauga, Ontario

ProSoft™ TQ1172 Softener

8306

8/22/2011

December 10, 2012

Taminco Inc., Allentown, Pennsylvania

Vantex T

8314

13-Jan-2011

October 19, 2012

Taminco Inc., Allentown, Pennsylvania

Advantex

8315

13-Jan-2011

October 19, 2012

Weatherford Engineered Chemistry Canada Ltd., Edmonton, Alberta

WSF-100

8320

28/May/2012

January 8, 2013

Win Manuco Ltd., Burlington, Ontario

APW

8322

April 16, 2012

November 9, 2012

Baker Petrolite Corp., Sugar Land, Texas

CRW9124 CORROSION INHIBITOR

8334

9/20/2011

December 14, 2012

Baker Petrolite Corp., Sugar Land, Texas

CGW9994 CORROSION INHIBITOR

8335

9/20/2011

December 18, 2012

Baker Petrolite Corp., Sugar Land, Texas

CGW3360 CORROSION INHIBITOR

8336

9/20/2011

December 17, 2012

Chevron Lummus Global, LLC, Richmond, California

Chevron ISODEWAXING® Catalyst ICR 424 (AII)

8339

April 26, 2012

December 19, 2012

E.I. du Pont Canada Company, Mississauga, Ontario

Capstone® FS-60 Fluorosurfactant

8344

11/14/2011

December 7, 2012

E.I. du Pont Canada Company, Mississauga, Ontario

Capstone® FS-61 Fluorosurfactant

8345

11/14/2011

December 7, 2012

3M Canada Company, London, Ontario

3M (TM) General Purpose Cleaner Concentrate (Product No. 8, Twist ’n Fill (TM) System)

8346

2011/10/06

February 15, 2013

Nalco Canada Co., Burlington, Ontario

FLEXSORB® SE EC9016A

8348

2011/10/17

October 25, 2012

Nalco Canada Co., Burlington, Ontario

EC3081A

8350

2011/10/17

October 10, 2012

GE Water & Process Technologies Canada, Oakville, Ontario

Thermoflo 7002

8354

24-OCT-2011

February 21, 2013

Cytec Industries Inc., Woodland Park, New Jersey

AERO® MX-5160 Promoter

8358

05/14/2012

December 10, 2012

Cytec Industries Inc., Woodland Park, New Jersey

DAPCO ™ 3041FR Self Extinguishing, Composite Bonding Epoxy Adhesive, Part A

8360

10/15/2010

December 10, 2012

BWA Water Additives US LLC, Tucker, Georgia

BELCLENE 499

8364

19/10/2011

January 10, 2013

BWA Water Additives US LLC, Tucker, Georgia

BELLASOL S60

8365

19/10/2011

October 9, 2012

Pulcra Chemicals, LLC, Rock Hill, South Carolina

KATAX 6760L

8366

08/23/2012

November 16, 2012

Power Service Product Inc., Weatherford, Texas

CLEAR-DIESEL FUEL AND TANK CLEANER, CONCENTRATED FORMULA

8369

April 15, 2011

November 22, 2012

Power Service Product Inc., Weatherford, Texas

CLEAR-DIESEL FUEL AND TANK CLEANER

8370

April 15, 2011

October 30, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer CFT 1900

8387

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer CFT 2000

8388

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer CFT 2100

8389

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer CFT 2200

8390

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer CFT2400

8391

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer CFT 2500

8392

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1000

8393

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1100

8394

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1200

8395

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1300

8396

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1400

8397

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1500

8398

10/4/2012

November 13, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1600

8399

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1700

8400

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1800

8401

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 1900

8402

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 2000

8403

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 2100

8404

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 2200

8405

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 2400

8406

10/4/2012

December 7, 2012

Core Laboratories, Houston, Texas

Spectrachem® Tracer IWT 2500

8407

10/4/2012

December 7, 2012

Afton Chemical Corporation, Richmond, Virginia

HiTEC 8888F Performance Additive

8408

11/18/2011

January 31, 2013

Cytec Industries Inc., Woodland Park, New Jersey

HT® 424 Thixotropic Paste, Part A

8412

12/09/2011

October 30, 2012

Momentive Specialty Chemicals, Inc., Oshawa, Ontario

Fentak ™ UR0777

8415

08-MAY-2012

December 17, 2012

Momentive Specialty Chemicals, Inc., Oshawa, Ontario

Fentak ™ MR0953

8416

08/MAY/2012

February 24, 2013

Trican Well Service Ltd., Calgary, Alberta

FA-1

8418

Nov 29, 2011

February 18, 2013

Trican Well Service Ltd., Calgary, Alberta

TTA

8419

Nov 29, 2011

March 21, 2013

Baker Petrolite Corporation, Sugar Land, Texas

LIFESPAN™ 3500 HEAVY OIL STABILIZER

8423

12/13/2011

January 23, 2013

DuraSystems Barriers Inc., Vaughan, Ontario

Type SFI-A Resin

8424

28 May 2012

February 1, 2013

DuraSystems Barriers Inc., Vaughan, Ontario

SFI-B Hardener

8425

28 May 2012

February 1, 2013

3M Canada Company, London, Ontario

SCOTCHKOTE 6233-4G, 6233-11G FUSION BONDED EPOXY COATING

8426

2011/12/19

March 25, 2013

Oilflow Solutions Inc., Calgary, Alberta

SI-101

8427

14th May 2012

November 20, 2012

Sealed Air Corporation, Brampton, Ontario

INSTAFILL® COMPONENT “B”

8431

12/20/2011

February 22, 2013

Sealed Air Corporation, Brampton, Ontario

INSTAPAK® MOLDING FOAM COMPONENT “B”

8432

12/20/2011

February 22, 2013

Sealed Air Corporation, Brampton, Ontario

INSTAFLEX® COMPONENT “B”

8433

12/20/2011

February 22, 2013

Sealed Air Corporation, Brampton, Ontario

GFLEX® COMPONENT “B”

8434

12/20/2011

February 22, 2013

Sealed Air Corporation, Brampton, Ontario

INSTAPAK® RIGID 125 COMPONENT “B”

8435

12/20/2011

February 22, 2013

Sealed Air Corporation, Brampton, Ontario

INSTAPAK® RIGID 150 COMPONENT “B”

8437

12/20/2011

February 22, 2013

Sealed Air Corporation, Brampton, Ontario

ULTRALITE® COMPONENT “B”

8438

12/20/2011

March 21, 2013

Sealed Air Corporation, Brampton, Ontario

GFLEX® QS-COMPONENT “B”

8439

12/20/2011

March 21, 2013

Sealed Air Corporation, Brampton, Ontario

INSTAPAK® RT COMPONENT “B”

8442

12/10/2010

March 21, 2013

G.E. Water & Process Technologies Canada, Oakville, Ontario

GENGARD GN8117

8446

18-APR-2012

March 25, 2013

Calfrac Well Services Ltd., Calgary, Alberta

DWP-107

8454

December 22, 2011

March 25, 2013

Calfrac Well Services Ltd., Calgary, Alberta

DWP-214

8455

December 22, 2011

March 21, 2013

Calfrac Well Services Ltd., Calgary, Alberta

DWP-218

8456

December 22, 2011

March 21, 2013

Calfrac Well Services Ltd., Calgary, Alberta

DWP-219

8457

December 22, 2011

March 21, 2013

Calfrac Well Services Ltd., Calgary, Alberta

DWP-922

8459

December 22, 2011

February 25, 2013

Calfrac Well Services, Calgary, Alberta

DAP-925

8462

January 19, 2012

March 21, 2013

Afton Chemical Corporation, Richmond, Virginia

ACTRAMIDE 303

8463

1/4/2012

January 31, 2013

Afton Chemical Corporation, Richmond, Virginia

HiTEC 6457 Fuel Additive

8465

1/4/2012

January 31, 2013

MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina

PAVE ™ 192

8467

6/04/2012

March 14, 2013

Momentive Specialty Chemicals Inc., Oshawa, Ontario

EPIKURE™ Curing Agent 3290

8468

29-FEB-2012

December 14, 2012

Momentive Specialty Chemicals Inc., Oshawa, Ontario

EPIKURE™ Curing Agent 6870-W-53

8470

07-MAR-2012

January 11, 2013

Baker Petrolite Corp., Sugar Land, Texas

RE4267

8483

1/20/2012

December 20, 2012

Baker Petrolite Corp., Sugar Land, Texas

CRW9139 CORROSION INHIBITOR

8485

1/26/2012

March 8, 2013

The Lubrizol Corporation, Wickliffe, Ohio

POWERZOL(TM) 9541

8487

26 May 2012

January 30, 2013

The Lubrizol Corporation, Wickliffe, Ohio

POWERZOL(TM) 9543

8488

26 May 2012

January 30, 2013

The Lubrizol Corporation, Wickliffe, Ohio

POWERZOL(TM) 9539

8489

25 May 2012

January 30, 2013

Nalco Canada Co., Burlington, Ontario

NALCO® EC3275A

8497

2012/02/14

February 11, 2013

Nalco Canada Co., Burlington, Ontario

EC3018A ANTIFOULANT

8499

2012/02/14

January 3, 2013

Nalco Canada Co., Burlington, Ontario

NALCO® EC3276A

8501

2012/02/14

February 11, 2013

BASF Canada, Inc., Mississauga, Ontario

Plurafac® SLF 18B-45

8504

2012/05/23

October 9, 2012

Baker Petrolite Corp., Sugar Land, Texas

CRO396 CORROSION INHIBITOR

8509

2/13/2012

January 11, 2013

The Lubrizol Corporation, Wickliffe, Ohio

ALOX® 2100

8517

26 May 2012

December 13, 2012

The Lubrizol Corporation, Wickliffe, Ohio

ALOX® 2165

8518

26 May 2012

December 13, 2012

Momentive Performance Materials, Markham, Ontario

Niax® catalyst A-31

8521

06/07/2012

March 6, 2013

Momentive Performance Materials, Markham, Ontario

Niax® flame lamination additive FLE-220LF

8522

06/07/2012

March 18, 2013

Momentive Performance Materials, Markham, Ontario

Niax*catalyst A-440

8523

06/07/2012

February 24, 2013

Nalco Canada Co., Burlington, Ontario

NALFLOTE® 9897

8527

2012/03/06

March 12, 2013

Nalco Canada Co., Burlington, Ontario

NALCO® DVS4U021

8528

2012/03/06

March 12, 2013

Hydro Technologies (Canada) Inc., Québec, Quebec

HY BRITE® WM-5008

8533

29 février 2012 (fr.)

January 24, 2013

Baker Petrolite Corp., Sugar Land, Texas

TOLAD™ 9702 Additive

8538

2012/07/19

January 14, 2013

Trican Well Service Ltd., Calgary, Alberta

SS-4

8540

March 12, 2012

March 21, 2013

The Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 9660

8542

30 July 2012

March 20, 2013

The Lubrizol Corporation, Wickliffe, Ohio

LUBRIZOL® 9690

8543

23 July 2012

March 20, 2013

Baker Petrolite Corp., Sugar Land, Texas

TRETOLITE™ RBW987 REVERSE BREAKER

8577

2012/03/29

February 28, 2013

Wax Busters Ltd., Calgary, Alberta

WB-34

8591

April 24, 2012

February 27, 2013

Privista Inc., Overland Park, Kansas

Privista Activator

8592

08-May-2012

March 27, 2013

Privista Inc., Overland Park, Kansas

Privista Primer

8593

09-Aug-2012

March 27, 2013

BWA Water Additives US LLC, Decatur, Georgia* * formerly Tucker, Georgia

DP3562

8625

August 28th, 2012

March 4, 2013

BWA Water Additives US LLC, Decatur, Georgia* * formerly Tucker, Georgia

BELCLENE 440

8626

August 30th, 2012

March 14, 2013

E.I. du Pont Canada Company, Mississauga, Ontario

Dupont (TM) Cyrel (R) Cylosol Plate Washout Solution 2012

8630

July 5, 2012

January 31, 2013

Notes:

  1. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8100 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients and concentration of four ingredients.
  2. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the subject of the claim bearing Registry Number 8124 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  3. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the subject of the claim bearing Registry Number 8139 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of four ingredients.
  4. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the subject of the claim bearing Registry Number 8188 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  5. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8211 to be 3M™ Screen Printing UV Ink Series 9861 Light Green. The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK SERIES 9861 LIGHT GREEN.
  6. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8212 to be 3M™ Screen Printing UV Ink Series 9875 Process Cyan. The product identifier for the product on which the screening officer issued the decision is 9875 Process Cyan.
  7. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8213 to be 3M™ Screen Printing UV Ink Series 9879 Blue (GS). The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK SERIES 9879 BLUE (GS).
  8. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8214 to be 3M™ Screen Printing UV Ink Series 9882 Transparent Blue. The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK 9882 TRANSPARENT BLUE.
  9. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8215 to be 3M™ Screen Printing UV Ink Series 9891 Blue Violet. The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK SERIES 9891 BLUE VIOLET.
  10. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the subject of the claim bearing Registry Number 8246 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.
  11. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8257 to be SPUR+ 1015 LM Prepolymer. The product identifier for the product on which the screening officer issued the decision is SPUR+ 1015 LM Prepolymer Silyated Polyurethane Resin.
  12. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8267 to be DEHYPOUND® ADVANCED. The product identifier for the product on which the screening officer issued the decision is Dehypound® Advanced.
  13. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8270 to be VERSAMINE® C39. The product identifier for the product on which the screening officer issued the decision is Versamine® C39.
  14. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8271 to be DISPONIL AFX 4070. The product identifier for the product on which the screening officer issued the decision is Disponil® AFX 4070.
  15. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8274 to be WATERPOXY® 1455. The product identifier for the product on which the screening officer issued the decision is Waterpoxy® 1455.
  16. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8278 to be Simulated Anti-serum. The product identifier for the product on which the screening officer issued the decision is Simulated Anti-serum (Anti-A, Anti-B, Anti-RH).
  17. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8279 to be Simulated Blood. The product identifier for the product on which the screening officer issued the decision is Simulated Blood (Type A, Type B, Type AB, Type O).
  18. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8286 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  19. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8302 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  20. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8303 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  21. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8320 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of five ingredients.
  22. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on December 3, 2011, listed the subject of the claim bearing Registry Number 8358 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  23. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on December 3, 2011, listed the subject of the claim bearing Registry Number 8360 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  24. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on December 3, 2011, listed the subject of the claim bearing Registry Number 8408 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  25. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8423 to be the chemical identity of two ingredients and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients and concentration of three ingredients.
  26. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8424 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  27. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8425 to be the chemical identity of six ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  28. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8439 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  29. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8442 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  30. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8462 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  31. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8467 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients.
  32. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8468 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  33. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Numbers 8487 and 8488 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  34. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8497 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  35. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8501 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  36. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on April 28, 2012, listed the product identifier bearing Registry Number 8523 to be Niax® catalyst A-440. The product identifier for the product on which the screening officer issued the decision is Niax* catalyst A-440.
  37. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on April 28, 2012, listed the subject of the claim bearing Registry Number 8527 to be the chemical identity of seven ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  38. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on April 28, 2012, listed the subject of the claim bearing Registry Number 8528 to be the chemical identity of seven ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  39. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on June 30, 2012, listed the subject of the claim bearing Registry Number 8593 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  40. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on June 30, 2012, listed the subject of the claim bearing Registry Number 8625 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

There were no written representations from affected parties to the screening officer with respect to any of the above-mentioned claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the MSDSs in respect of the claims bearing Registry Numbers 8336, 8339, 8387, 8388, 8389, 8390, 8391, 8392, 8431, 8432, 8433, 8434, 8435, 8437, 8438, 8499, 8504, 8533, 8538, 8542, 8543, 8577 and 8625 complied with the applicable requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 8251 and 8253, being claims from an employer with operations in the province of Alberta, the screening officer found that the MSDSs and labels in respect of which the claims were filed did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2009 of the Province of Alberta.

In the case of the claims bearing Registry Numbers 8424 and 8425, being claims from an employer with operations in the province of Ontario, the screening officer found that the MSDSs in respect of which the claims were filed did not comply with the applicable disclosure requirements of the Occupational Health and Safety Act of the Province of Ontario.

In all cases where the MSDS or the label was determined not to be in compliance with the relevant legislation, the screening officer offered the claimant the possibility of entering into an undertaking whereby the claimant would voluntarily make the changes necessary to bring the MSDS or the label into compliance. Pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

In the case of the following claims, the claimant supplied the screening officer with a signed undertaking accompanied by the MSDS or label amended as necessary within the time frame specified. The screening officer was satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified therein.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of any information that has been disclosed on the relevant MSDS or label in compliance with an undertaking.

Registry Number 8073

Date of notice confirming acceptance: December 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 60 minutes.

  2. Disclose an LD50 (oral, male rat) value of 273 mg/kg for the hazardous ingredient “potassium hydroxide”.

  3. Disclose an LD50 (oral, rat) value of 5 119 mg/kg for the hazardous ingredient “dipropylene glycol monomethyl ether”.

  4. Disclose an LD50 (dermal, rabbit) value of 9 480 mg/kg for the hazardous ingredient “dipropylene glycol monomethyl ether”.

  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 8100

Date of notice confirming acceptance: March 12, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient “ethanol”, in the controlled product, together with its CAS registry number, in an acceptable manner.

  2. Disclose the ACGIH TLV–TWA Exposure Limit for the confidential hazardous ingredient “aldehyde” and show that “aldehyde” has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH).

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes while holding the eyelids open.

  4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  5. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product; avoid or eliminate ignition sources when working with the controlled product and store the product away from ignition sources and heat, and that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  6. Disclose an LD50 (dermal, rabbit) value of 2.03 mL/kg for the confidential hazardous ingredient “alcohol 2”.

  7. Disclose an LC50 (vapour, rat, 0.5 hours) value of 1 mg/L for the confidential hazardous ingredient “aldedyde”.

  8. Disclose that acute oral exposure to the hazardous ingredient “ethanol” in the controlled product has been shown to cause central nervous system (CNS) effects in humans.

  9. Disclose that acute oral exposure to the hazardous ingredients “ethanol” and “aldehyde” in the controlled product has been shown to cause adverse effects of the digestive system in laboratory animals.

  10. Disclose that acute inhalation of the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause nasal cavity effects in laboratory animals.

  11. Disclose that chronic ingestion of the hazardous ingredient “ethanol” in the controlled product has been shown to cause adverse sperm, liver and heart effects in laboratory animals.

  12. Disclose that chronic ingestion of the confidential hazardous ingredient “alcohol 2” in the controlled product has been shown to cause adverse effects of the red blood cells in laboratory animals.

  13. Disclose that the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause skin sensitization in laboratory animals.

  14. Disclose that the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause adverse effects of the respiratory system in humans.

  15. Disclose the International Agency for Research on Cancer (IARC) Group 1 classification for the confidential hazardous ingredient “aldehyde”.

  16. Disclose that the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause mutagenic effects in humans and animal cells, in vivo.

  17. Disclose that the hazardous ingredient “ethanol” in the controlled product has been shown to cause synergistic and potentiating effects with halogenated hydrocarbons and aldehydes in laboratory animals.

  18. Disclose that the hazardous ingredient “ethanol” in the controlled product has been shown to cause teratogenic and fetotoxic effects, in the presence of maternal toxicity, in humans.

Registry Number 8139

Date of notice confirming acceptance: November 6, 2012

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of four confidential hazardous ingredients “inorganic sulfate salt 1”, “inorganic sulfate salt 2”, “inorganic sulfate salt 3”, and “inorganic sulfate salt 4”, in the controlled product, together with their percent concentration, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 30 minutes.

  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  5. Disclose an ACGIH TLV–TWA Exposure Limit of 0.1 mg/m3 for the confidential hazardous ingredient “inorganic sulfate salt 4”.

  6. Add oxides of sulphur to the list of hazardous decomposition products.

  7. Disclose that the confidential hazardous ingredient “inorganic sulfate salt 4” in the controlled product has been shown to cause respiratory sensitization and has been shown to cause adverse effects of the respiratory system.

Registry Number 8173

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

  2. Add oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.

Registry Number 8181

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “oxygenated aromatic derivative” in the controlled product has been shown to cause skin sensitization in laboratory animals.

  2. Disclose an LD50 (oral, rat) value of 1 120 mg/kg for the confidential hazardous ingredient “oxygenated aromatic derivative”.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.

  4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro, and teratogenic and fetotoxic effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8184

Date of notice confirming acceptance: October 25, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product is corrosive to the eyes.

  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with gently flowing water for at least 30 minutes.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that skin should be washed with gently flowing water for at least 20 minutes.

  4. Remove oxides of sulphur from the list of hazardous decomposition products.

  5. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “amine ethoxylate”.

Registry Number 8188

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “methylene phenylene isocyanate” and “diisocyanate polymer”, in the controlled product, in an acceptable manner.

  2. Add hydrogen chloride to the list of hazardous decomposition products.

Registry Number 8211

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

  2. Add hydrogen chloride to the list of hazardous combustion products.

Registry Number 8212

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

  2. Disclose the chemical identity of the confidential an additional hazardous ingredient, “xylene”, in the controlled product, together with its CAS registry number and percent concentration, in an acceptable manner.

Registry Number 8213

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

Registry Number 8214

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

Registry Number 8215

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

  2. Add hydrogen chloride to the list of hazardous combustion products.

Registry Number 8246

Date of notice confirming acceptance: March 5, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “resin alkyd” and “resin acid ester polymer”, in the controlled product, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for 20 minutes or until the chemical is removed.

  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

  4. Disclose an LD50 (oral, female rat) value of 1 220 mg/kg for the hazardous ingredient “cobalt octoate”.

  5. Add oxides of nitrogen, oxides of sulphur and hydrogen chloride to the list of hazardous thermal decomposition products.

  6. Disclose that an ingredient in the controlled product is a skin irritant.

  7. Disclose the International Agency for Research on Cancer (IARC) Group 1 classification for one hazardous ingredient and Group 2B classification for two other hazardous ingredients.

  8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 8247

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS hazard symbols are displayed on the MSDS, disclose the appropriate hazard symbols for the product.

  2. Disclose the chemical identity of two additional hazardous ingredients, “fatty acid esters” and “amine borate mixture”, in the controlled product, together with their CAS registry numbers and percent concentration, in an acceptable manner.

Registry Number 8251

Date of notice confirming acceptance: January 17, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS and the content of the label. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

  2. Disclose an ACGIH TLV–STEL Exposure Limit of 150 ppm for the confidential hazardous ingredient “aromatic solvent 1”.

  3. Disclose an ACGIH TLV–STEL Exposure Limit of 250 ppm for the hazardous ingredient “methyl alcohol”.

  4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  5. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  6. Disclose that the hazardous ingredient “methyl alcohol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity.

Registry Number 8253

Date of notice confirming acceptance: January 17, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS and the content of the label. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–STEL Exposure Limit of 150 ppm for the confidential hazardous ingredient “aromatic solvent 1”.

  2. Disclose an ACGIH TLV–STEL Exposure Limit of 250 ppm for the hazardous ingredient “methyl alcohol”.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  4. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  5. Disclose that the hazardous ingredient “methyl alcohol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity.

Registry Number 8254

Date of notice confirming acceptance: March 5, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant has been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, female rat) value of 5 155 mg/kg for the hazardous ingredient “1-methyloxy-2-propyl acetate”.

  2. Disclose an LD50 (dermal, rabbit) value of 9.49 g/kg for the hazardous ingredient “ethyl 3-ethoxypropionate”.

  3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and bacteria cells, in vitro.

Registry Number 8257

Date of notice confirming acceptance: April 16, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.

  2. Disclose the chemical identity of an additional hazardous ingredient, “methanol”, in the controlled product, together with its CAS registry number and the percent concentration in an acceptable manner.

  3. Disclose correct information concerning the proper storage conditions for the controlled product.

  4. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm with skin notation for the hazardous ingredient “methanol”.

  5. Add oxides of nitrogen to the list of hazardous thermal decomposition products.

  6. Disclose a statement to the effect that contact of the controlled product with water should be avoided.

  7. Disclose oral and dermal LD50 values and an inhalation LC50 value for the confidential hazardous ingredient “organosilane ester” in an acceptable manner.

  8. Disclose that the confidential hazardous ingredient “organosilane ester” in the controlled product has been shown to cause skin sensitization in laboratory animals.

  9. Disclose that the hazardous ingredient “methanol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8261

Date of notice confirming acceptance: December 3, 2012

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 30 minutes.

  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement “dilute contents of stomach using 4–10 fluid ounces (120–300 mL) of milk or water”.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  4. Add oxides of carbon to the list of hazardous thermal decomposition products.

Registry Number 8267

Date of notice confirming acceptance: May 22, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “ethoxylated alcohol”, in the controlled product, in an acceptable manner.

  2. Add oxides of carbon to the list of hazardous thermal decomposition products.

Registry Number 8271

Date of notice confirming acceptance: January 11, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient, “alcohols, C12-14-secondary, b-(2-hydroxyethoxy), ethoxylated”, in the controlled product, together with the percent concentration of 7%.

  2. Add oxides of carbon to the list of hazardous thermal decomposition products.

Registry Number 8278

Date of notice confirming acceptance: March 18, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “inorganic salt 1”, in the controlled product, in an acceptable manner.

  2. Add oxides of sulphur to the list of hazardous decomposition products.

  3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and teratogenic effects and adverse reproductive effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8279

Date of notice confirming acceptance: March 18, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the controlled product is an eye irritant.

  2. Disclose that the confidential hazardous ingredient “nitrate salt 2” is present in blood type AB.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with gently flowing water for at least 20 minutes or until the chemical is removed.

  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

  5. Add oxides of nitrogen to the list of hazardous thermal decomposition products.

  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 8285

Date of notice confirming acceptance: March 25, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of four additional hazardous ingredients, “alcohols, C10-16, ethoxylated propoxylated”, “fatty acids, C8-18 and C18-Unsat., compds. with isopropanolamine”, “fats and clyceridic oils, vegetable, polymd., oxidized”, and “2, 5-Furandione, dihydro-, monopolyisobutenyl dirvs., reaction products with triethanolamine”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.

  2. Disclose that an ingredient in the controlled product can be corrosive to the eyes.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes while holding the eyelids open and that medical attention must be obtained immediately.

  4. Disclose an LD50 (oral, rat) value of 4.26 g/kg and an LD50 (dermal, rabbit) value of 1.64 mL/kg for the confidential hazardous ingredient “monoisopropanolamine”.

Registry Number 8286

Date of notice confirming acceptance: January 22, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of two additional confidential hazardous ingredients, “polyolefin amide alkyleneamine, borated” and “long-chain hydrocardon”, in the controlled product, together with their percent concentrations, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “long-chain alkenyl alkanol amide”.

Registry Number 8293

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–TWA Exposure Limit of 2 mg/m3 for the confidential hazardous ingredient “borate salt”.

  2. Disclose an LD50 (oral, rat) value of 1 660–3 350 mg/kg for the controlled product.

  3. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with lukewarm, flowing water for 60 minutes, that contaminated clothing, shoes and leather goods should be removed under running water, and that medical attention must be obtained immediately.

  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water or milk to drink.

Registry Number 8296

Date of notice confirming acceptance: November 19, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “inorganic base”, in the controlled product, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 60 minutes.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  4. Disclose that chronic exposure to an ingredient in the product has been shown to cause adverse effects on the respiratory system.

Registry Number 8298

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 1.0 g/kg and an LD50 (dermal, rat) value of 5.0 g/kg for the confidential hazardous ingredient “ethoxylated alcohol (1)”.

  2. Disclose an LD50 (oral, rat) value of 1.4 g/kg and an LD50 (dermal, rabbit) value of 2.0 g/kg for the confidential hazardous ingredient “ethoxylated alcohol (2)”.

Registry Number 8299

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS.

Registry Number 8300

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TVL–TWA Exposure Limit of 25 ppm for the hazardous ingredient “isobutyl ketone”.

Registry Number 8302

Date of notice confirming acceptance: February 28, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional confidential hazardous ingredient, “organic acid salt”, in the controlled product, together with its percent concentration, in an acceptable manner.

Registry Number 8303

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of two additional confidential hazardous ingredients, “polyacrylamide polymer” and “mineral oil”, in the controlled product, together with their percent concentration, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of 1 480 mg/kg and an LD50 (dermal, rabbit) value of 2 970 mg/kg for the confidential hazardous ingredient “ethoxylated nonyl phenol”.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for at least 20 minutes or until the chemical is removed and that contaminated clothing, shoes and leather goods should be removed under running water.

  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

  5. Disclose that exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8306

Date of notice confirming acceptance: December 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredients “quarternary amide” and “alkoxylated alcohol”, in the controlled product, in an acceptable manner.

  2. Disclose the HMIRC registry number and date, in an acceptable manner.

Registry Number 8314

Date of notice confirming acceptance: October 25, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the HMIRC registry number and date, in an acceptable manner.

Registry Number 8315

Date of notice confirming acceptance: October 25, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the HMIRC registry number and date, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that medical attention must be obtained immediately.

Registry Number 8320

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed gently with water for 20 minutes.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.

  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water to drink.

  5. Add oxides of nitrogen and hydrogen chloride to the list of hazardous decomposition products.

  6. Disclose an LD50 (oral, rat) value of >500 mg/kg and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “alkyl glycol”.

  7. Disclose an LD50 (oral, rat) value of >500 mg/kg, an LD50 (dermal, rabbit) value of >1 000 mg/kg and an LC50 (vapour, female rat, 4 hours) value of >2 500 ppm for the confidential hazardous ingredient “alcohol 2”.

  8. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “sodium alkylbenzenesulfonate”.

  9. Disclose that ingestion of the confidential hazardous ingredient “alkyl glycol” has been shown to cause kidney and neurological effects in humans.

  10. If the WHMIS classifications are stated on the MSDS, disclose the B2 classification.

Registry Number 8322

Date of notice confirming acceptance: December 3, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 20 minutes and that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  3. Disclose that under conditions of reduced ventilation that use of an approved National Institute for Occupational Safety and Health (NIOSH) organic vapour respirator respiratory is recommended.

  4. Disclose an LD50 (oral, rat) value of 798.1 mg/kg for the controlled product.

Registry Number 8334

Date of notice confirming acceptance: January 8, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that artificial respiration or cardiopulmonary resuscitation should be administered immediately if breathing has stopped or the heart has stopped.

Registry Number 8335

Date of notice confirming acceptance: January 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8344

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute ingestion and inhalation of an ingredient in the controlled product has been shown to cause low blood pressure and central nervous system (CNS) effects in both humans and laboratory animals.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  3. Add oxides of nitrogen and oxides of sulphur to the list of hazardous combustion products.

  4. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  5. Disclose that an ingredient in the controlled product is incompatible with chromium trioxide.

Registry Number 8345

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 8346

Date of notice confirming acceptance: March 5, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient, “alkyl glycoside (2)”, in the controlled product, in an acceptable manner.

Registry Number 8348

Date of notice confirming acceptance: January 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8350

Date of notice confirming acceptance: October 16, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

Registry Number 8354

Date of notice confirming acceptance: March 28, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8358

Date of notice confirming acceptance: January 28, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

Registry Number 8360

Date of notice confirming acceptance: January 28, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “modified epoxy resin”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose the presence of two additional hazardous ingredients, “decabromodiphenyl oxide” and “silica siliconized”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.

  3. Disclose an LC50 (rat, 4 hours) value of 315–708 mg/m3 for the hazardous ingredient “silica siliconized”.

Registry Number 8364

Date of notice confirming acceptance: January 22, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that if the casualty is rapidly losing consciousness, convulsing or is unconscious, vomiting should not be induced and fluids should not be offered to drink.

  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that medical attention must be obtained immediately.

Registry Number 8365

Date of notice confirming acceptance: October 15, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8366

Date of notice confirming acceptance: November 21, 2012

The claimant had been advised to amend certain aspects of the content and format of the MSDS.

Registry Number 8369

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product can be corrosive to the eyes and skin.

  2. Disclose that acute and chronic oral, skin and inhalation exposure to an ingredient in the controlled product has been shown to cause blood cell destruction in laboratory animals.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes and that medical attention must be obtained immediately.

  4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 30 minutes, that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.

  5. Disclose that the hazardous ingredient “butyl glycol ether” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).

  6. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in the presence of maternal toxicity in laboratory animals.

  7. If the WHMIS classifications and pictograms are stated on the MSDS, disclose that the controlled product is also in class E and disclose the E pictogram.

Registry Number 8370

Date of notice confirming acceptance: December 11, 2012

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute and chronic oral, skin and inhalation exposure to an ingredient in the controlled product has been shown to cause blood cell damage in laboratory animals.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for 20 minutes or until the chemical is removed.

  3. Disclose that the hazardous ingredient “butyl glycol ether” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).

Registry Numbers 8393, 8394, 8395, 8396, 8397 and 8398

Date of notice confirming acceptance: January 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Numbers 8399, 8400, 8401, 8402, 8403, 8404, 8405, 8406 and 8407

Date of notice confirming acceptance: December 21, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8408

Date of notice confirming acceptance: March 6, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional confidential hazardous ingredient, “substituted polyolefin amide alkeneamine”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of 510 mg/kg and an LD50 (dermal, rabbit) value of 1.9 g/kg for the confidential hazardous ingredient “alkaryl polyether”.

Registry Number 8412

Date of notice confirming acceptance: December 5, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for skin contact and ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for 20 minutes or until the chemical is removed.

  4. Disclose that the hazardous ingredient “formaldehyde” has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH).

  5. Disclose that the hazardous ingredient, “phenol” in the controlled product has been shown to cause mutagenic effects in animal cells and bacteria, in the absence and/or presence of metabolic activation, in vitro.

Registry Number 8415

Date of notice confirming acceptance: August 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that artificial respiration or cardiopulmonary resuscitation should be administered immediately if breathing has stopped or the heart has stopped.

  2. Disclose an AIHA WEEL–TWA value of 10 mg/m3 for the hazardous ingredient “diethylene glycol”.

Registry Number 8418

Date of notice confirming acceptance: February 27, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that skin should be washed with gently flowing water for at least 30 minutes and that medical attention must be obtained immediately.

  2. Add oxides of carbon to the list of hazardous decomposition products.

Registry Number 8419

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the hazardous ingredient “crystalline silica (quartz)”, in the controlled product, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 60 minutes.

  3. Add oxides of carbon to the list of hazardous combustion products.

Registry Number 8423

Date of notice confirming acceptance: February 11, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute dermal exposure to the hazardous ingredient “heavy aromatic naphtha” in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.

  2. Disclose an LC50 (female rat, 4 hours) value of 1.72 mg/L for the confidential hazardous ingredient “hydrocarbon”.

Registry Number 8424

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications and pictograms are stated on the MSDS, disclose that the controlled product is also in class D1A and the D1A pictogram.

  2. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “aliphatic alcohol”, in the controlled product, together with its percent concentration, in an acceptable manner.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes.

  4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that vomiting should not be induced, medical attention must be obtained immediately and that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  5. Disclose an ACGIH TLV–STEL Exposure Limit of 15 ppm with a skin notation for the confidential hazardous ingredient “alcohol solvent”.

  6. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm for the confidential hazardous ingredient “aliphatic alcohol”.

  7. Add oxides of carbon and oxides of nitrogen to the list of hazardous thermal decomposition products.

  8. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in humans.

  9. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.

  10. Disclose an LD50 (oral, rat) value and an LC50 (vapour, rat 4 hours) value for the confidential hazardous ingredient “alcohol solvent”, in an acceptable manner.

  11. Disclose an LD50 (oral, rat) value and an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “sugar alcohol”, in an acceptable manner.

  12. Disclose an LD50 (oral, guinea pig) value of 260 mg/kg and an LC50 (vapour, rat, 4 hours) value of 300 ppm for the hazardous ingredient “formaldehyde”, in an acceptable manner.

  13. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vivo and in vitro.

  14. Disclose that an ingredient in the controlled product has been classified Group 1 by the International Agency for Research on Cancer (IARC).

  15. Disclose that ingredients in the controlled product have been shown to cause teratogenic and embryotoxic/fetotoxic effects in laboratory animals.

Registry Number 8425

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with flowing water for 30 minutes and that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  3. Add oxides of carbon and oxides of nitrogen to the list of hazardous thermal decomposition products.

Registry Number 8426

Date of notice confirming acceptance: April 9, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Number 8427

Date of notice confirming acceptance: January 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two to four cups of water or milk.

  3. Add oxides of carbon to the list of hazardous combustion/ decomposition products.

Registry Number 8439

Date of notice confirming acceptance: August 6, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8442

Date of notice confirming acceptance: August 6, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS.

Registry Number 8446

Date of notice confirming acceptance: April 15, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with flowing water for 60 minutes.

  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to dilute contents of stomach using 4–10 fluid ounces (120–300 mL) of water or milk.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  4. Add oxides of carbon, nitrogen and sulphur, and hydrogen chloride to the list of hazardous thermal decomposition products.

Registry Number 8454

Date of notice confirming acceptance: May 27, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, flowing water for 30 minutes and that medical attention must be obtained immediately.

  2. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

  3. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “organic acid”.

  4. Disclose that the confidential hazardous ingredient “organic acid” in the controlled product has been shown to cause eye corrosion in laboratory animals.

Registry Numbers 8455, 8456 and 8457

Date of notice confirming acceptance: May 27, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 30 minutes.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  3. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

  4. Disclose an LD50 (oral, rat) value and an LC50 (vapour, rat, 4 hours) value for the confidential hazardous ingredient “organic acid”, in an acceptable manner.

Registry Number 8459

Date of notice confirming acceptance: March 27, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8462

Date of notice confirming acceptance: April 23, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous combustion products.

  2. Disclose that the confidential hazardous ingredient “fatty acids” in the controlled product is a skin sensitizer.

Registry Number 8463

Date of notice confirming acceptance: March 6, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “long-chain carboxylic acid alkanolamine compound”, in the controlled product, together with its percent concentration, in an acceptable manner.

Registry Number 8465

Date of notice confirming acceptance: March 6, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient, “diethanolamine”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose that an ingredient in the controlled product has been classified in Group 2B by the International Agency for Research on Cancer (IARC).

  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 8467

Date of notice confirming acceptance: April 15, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional hazardous ingredient, “aliphatic carboxylic acids”, in the controlled product, together with its CAS registry number and percent concentration, in an acceptable manner.

Registry Number 8468

Date of notice confirming acceptance: August 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.

  2. Disclose the generic chemical identity of two additional confidential hazardous ingredients, “propoxylated polyethylenepolyamine #1” and “propoxylated polyethylenepolyamine #2”, in the controlled product, together with their percent concentration, in an acceptable manner.

  3. Add oxides of nitrogen to the list of hazardous combustion products.

  4. Disclose an AIHA WEEL–TWA Exposure Limit of 1 ppm with a skin notation for the confidential hazardous ingredient “polyethylenepolyamine”.

  5. Disclose an ACGIH Exposure Limit with a skin notation for the confidential hazardous ingredient “propoxylated polyethylenepolyamine #1”.

Registry Number 8470

Date of notice confirming acceptance: July 29, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8483

Date of notice confirming acceptance: January 14, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

Registry Number 8485

Date of notice confirming acceptance: March 25, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  2. Disclose an LD50 (oral, rat) value of 239.9 mg/kg for the confidential hazardous ingredient “quaternary ammonium compound”.

Registry Number 8487

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “substituted aliphatic amine”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the hazardous ingredient “petroleum naphtha”.

Registry Number 8488

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “substituted aliphatic amine”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the hazardous ingredient “petroleum naphtha”.

Registry Number 8489

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the hazardous ingredient “petroleum naphtha”.

Registry Numbers 8497 and 8501

Date of notice confirming acceptance: May 1, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “substituted alkylamine” in the controlled product has been shown to cause eye corrosion in laboratory animals.

  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with gently flowing water for at least 30 minutes.

  3. Disclose an AIHA WEEL–TWA Exposure Limit of 100 ppm for the confidential hazardous ingredient “aliphatic alcohol(1)”.

  4. Disclose an ACGIH TVL–TWA Exposure Limit of 100 ppm and an ACGIH TVL–STEL Exposure Limit of 125 ppm for the confidential hazardous ingredient “aliphatic alcohol(2)”.

  5. Disclose that the confidential hazardous ingredient “substituted alkylamine” in the controlled product has been shown to cause mutagenic effects in bacterial cells.

Registry Number 8509

Date of notice confirming acceptance: January 25, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8517

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8518

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of sulphur to the list of hazardous decomposition products.

Registry Number 8521

Date of notice confirming acceptance: April 15, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  3. Disclose that the confidential hazardous ingredient “alkylphenol ethoxylate” in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8522

Date of notice confirming acceptance: April 23, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “diol ester”.

Registry Number 8523

Date of notice confirming acceptance: March 28, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water.

  3. Disclose that the confidential hazardous ingredient “Bis(2-dimethylaminoethyl)ether (BDMAEE)” in the controlled product has been shown to cause skin corrosion in rabbits.

  4. Disclose that the confidential hazardous ingredient “Bis(2-dimethylaminoethyl)ether (BDMAEE)” in the controlled product has been shown to cause teratogenic effects, in the presence of maternal toxicity, in laboratory animals.

Registry Numbers 8527 and 8528

Date of notice confirming acceptance: May 1, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, male rat) value of >500 mg/kg and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “ketone (2)”.

Registry Number 8540

Date of notice confirming acceptance: May 27, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8591

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  2. Disclose that an ingredient in the controlled product is incompatible with chromium trioxide.

  3. Disclose an LD50 (oral, rat) value of 3 000 mg/kg for the confidential hazardous ingredient “branched alkylphenol, ethoxylate”.

Registry Number 8592

Date of notice confirming acceptance: May 1, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “inorganic acid” in the controlled product has been shown to cause teratogenic/embryotoxic effects, in the absence of maternal toxicity, in laboratory animals.

Registry Number 8593

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product is incompatible with potassium.

  2. Disclose that the confidential hazardous ingredient “inorganic acid” in the controlled product has been shown to cause teratogenic/embryotoxic effects, in the absence of maternal toxicity, in laboratory animals.

Registry Number 8626

Date of notice confirming acceptance: April 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen and oxides of sulphur to the list of hazardous thermal decomposition products.

Registry Number 8630

Date of notice confirming acceptance: February 18, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 20 minutes and that medical attention must be obtained immediately.

  2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

CLAIMS FOR WHICH THE SCREENING OFFICER ORDERED THE CLAIMANT TO COMPLY WITH THE APPLICABLE DISCLOSURE REQUIREMENTS

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of any information that the screening officer ordered to be disclosed on an MSDS or a label reviewed by the screening officer.

Registry Number 8124

Date of order: December 11, 2012

The claimant has been ordered to amend certain aspects of the content, format and wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of five additional confidential hazardous ingredients, “phosphoric acid”, “oxo alcohol (A)”, “oxo alcohol (B)”, “glycol ether” and “organo phosphorous compound”, in the controlled product, together with their percent concentrations, in an acceptable manner.

  2. Disclose an LD50 (oral, mouse) value of >500 mg/kg for the confidential hazardous ingredient “oxo alcohol (A)”.

  3. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “oxo alcohol (B)”.

  4. Disclose an LD50 (oral, rat) value of >500 mg/kg and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “glycol ether”.

  5. Disclose an LD50 (oral, male rat) value of >500 mg/kg and an LC50 (aerosol, rat, 1 hour) value of >2.5 mg/L for the confidential hazardous ingredient “organo phosphorous compound”.

  6. Disclose an AIHA WEEL–TWA Exposure Limit of 50 ppm for the confidential hazardous ingredient “oxo alcohol (A)”.

  7. Disclose an ACGIH TVL–TWA Exposure Limit of 2.2 mg/m3 for the confidential hazardous ingredient “organo phosphorous compound”.

  8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause urinary bladder and liver effects in laboratory animals.

  9. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause postnatal and fetotoxic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8270

Date of order: July 23, 2013

The claimant has been ordered to amend certain aspects of the wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose that oral exposure to the hazardous ingredient “benzyl alcohol” in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.

  2. Disclose that the hazardous ingredient “benzyl alcohol” in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

  3. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “cycloaliphatic amine adduct”, in the controlled product, in an acceptable manner.

  4. Disclose an AIHA WEEL–TWA value of 10 ppm for the hazardous ingredient “benzyl alcohol”.

  5. Add oxides of carbon, oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

  6. Disclose an LD50 (oral, rat) value of 1 230 mg/kg for the hazardous ingredient “benzyl alcohol”.

Registry Number 8274

Date of order: July 23, 2013

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of the confidential hazardous ingredient “alkyl alkoxylated epoxide”, in the controlled product, in an acceptable manner.

  2. Disclose the presence of an additional hazardous ingredient, “propanol, 1 (or 2)- ethoxy”, in the controlled product, together with its percent concentration, in an acceptable manner.

  3. Add oxides of carbon, oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

  4. Disclose an ACGIH TLV–TWA Exposure Limit of 100 mg/m3 (ceiling) for the hazardous ingredient “ethylene glycol”.

  5. Disclose that ingestion of the hazardous ingredient “ethylene glycol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity, in laboratory animals.

Note: The following claims, 8158, 8275 and 8416, were cancelled after the issuance of the decisions; thus, neither a signed undertaking was provided nor was an order issued. The screening officer has identified the following instances of non-compliance with the requirements of the relevant legislation.

Registry Number 8158

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. Disclose an LC50 (aerosol, male rat) value of 1.72 mg/L for the hazardous ingredient “distillates (petroleum), hydrotreated light”.

  2. Disclose a lower LD50 (dermal, rabbit) value of 2 764 mg/kg for the hazardous ingredient “diethylene glycol monobutyl ether”.

  3. Disclose an LD50 (oral, rat) value of 5.3 g/kg for the hazardous ingredient “triethylene glycol butyl ether”.

  4. Disclose three additional confidential hazardous ingredients, “9,12-octadecadienamide, N,N-bis(2-hydroxyethyl)-”, “diethanolamine” and “fatty acids, tall oil”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.

  5. Disclose an LD50 (oral, rat) value of 10.5 g/kg for the hazardous ingredient “9,12-octadecadienamide, N,N-bis(2-hydroxyethyl)-”.

  6. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 (skin) for the hazardous ingredient “diethanolamine”.

  7. Disclose that an ingredient in the controlled product has been classified Group 2B by the International Agency for Research on Cancer (IARC).

  8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in the presence of metabolic activation, in vitro.

  9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 8275

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed gently with water for 20 minutes.

  2. Disclose an AIHA WEEL–TWA value of 25 ppm for the confidential hazardous ingredient “glycol ether”.

  3. Disclose an ACGIH TLV–STEL Exposure Limit of 150 ppm for the hazardous ingredient “dipropylene glycol methyl ether”.

  4. Disclose an LD50 (dermal, female rabbit) value of 8.48 g/kg for the confidential hazardous ingredient “glycol ether”.

  5. Disclose an LD50 (dermal, male rabbit) value of 9.48 g/kg for the confidential hazardous ingredient “dipropylene glycol methyl ether”.

  6. Disclose that ingestion of and dermal exposure to an ingredient in the controlled product have been shown to cause central nervous system (CNS) effects in laboratory animals.

  7. Disclose that dermal exposure of an ingredient in the controlled product has been shown to cause kidney effects.

Registry Number 8416

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. Disclose that the confidential hazardous ingredient “fatty acid” in the controlled product is a skin sensitizer.

  2. Disclose the chemical identity of two additional confidential hazardous ingredients, “9-octadecenoic acid (9Z)-, compound with 2-aminoethanol” and “phosphoric acid, 2-ethylhexyl ester, compound with 2-aminoethanol”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.

  3. Disclose an OSHA TLV–STEL Exposure Limit of 150 ppm for the confidential hazardous ingredient “glycol ether”.

[38-1-o]

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments

Name and position

Order in Council

Bracken, The Hon. Keith

2013-912

Government of British Columbia

 

Administrator

 

September 16 to September 20, 2013

 

Fréchette, Jean-Denis

2013-903

Parliamentary Budget Officer

 

Government of Ontario

2013-909

Administrators

 

Hoy, The Hon. Alexandra H.

 

September 23 and from December 10 to December 20, 2013

 

Lauwers, The Hon. Peter D.

 

September 1 to September 6, 2013

 

Rosenberg, The Hon. Marc

 

September 17 to September 20, 2013

 

Smith, The Hon. Heather J.

 

September 30 to October 6, 2013, and from December 21, 2013, to January 5, 2014

 

Government of Saskatchewan

2013-910

Administrators

 

Cameron, The Hon. Stuart J.

 

October 7 to October 10, 2013

 

Lane, The Hon. J. Gary

 

September 30 to October 2, 2013

 

Ottenbreit, The Hon. Ralph K.

 

September 7 and September 8, 2013

 

Murphy, The Hon. Michele M.

2013-911

Government of Prince Edward Island

 

Administrator

 

September 14 to October 4, 2013

 

Proulx, Fernand

2013-907

National Museum of Science and Technology

 

Acting Director

 

Tedesco, Lucie

2013-908

Financial Consumer Agency of Canada

 

Commissioner

 

Usher, Marlene

2013-906

Enterprise Cape Breton Corporation

 

Acting Chief Executive Officer

 

September 13, 2013

DIANE BÉLANGER
Official Documents Registrar

[38-1-o]

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments

Name and position

Instrument of Advice dated September 3, 2013

Carignan, The Hon. Claude

Queen’s Privy Council for Canada

Member

September 13, 2013

DIANE BÉLANGER
Official Documents Registrar

[38-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:

Lester Parsons

Karl Piercey

Ottawa, September 9, 2013

KATHY THOMPSON
Assistant Deputy Minister
Law Enforcement and Policing Branch

[38-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

B2B Bank — Letters patent of amalgamation and order to commence and carry on business

Notice is hereby given of the issuance,

  • pursuant to subsection 229(1) of the Bank Act, of letters patent amalgamating and continuing B2B Bank and AGF Trust Company as one bank under the name in English, B2B Bank and in French, B2B Banque, effective on September 1, 2013; and
  • pursuant to subsection 48(4) of the Bank Act, of an order to commence and carry on business authorizing B2B Bank to commence and carry on business, effective on the date on which the letters patent of amalgamation become effective.

August 21, 2013

JULIE DICKSON
Superintendent of Financial Institutions

[38-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

Santander Consumer USA Inc. — Approval to have a financial establishment in Canada

Notice is hereby given, pursuant to subsection 522.211(1) of the Bank Act, that the Minister of Finance approved, on August 6, 2013, Santander Consumer USA Inc. to have a financial establishment in Canada.

August 21, 2013

JULIE DICKSON
Superintendent of Financial Institutions

[38-1-o]